JMD.F Japan Medical Dynamic Marketing INC
- Market cap
- EUR 44.8M
- P/E
- -
- P/B
- 0.34x
- ROE
- -6.7%
- Dividend yield
- 5.53%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is JMD.F undervalued?
Graham numberThe Graham number of Japan Medical Dynamic Marketing INC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Japan Medical Dynamic Marketing INC fundamental analysis
No fundamental analysis for Japan Medical Dynamic Marketing INC yet.
Japan Medical Dynamic Marketing INC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Japan Medical Dynamic Marketing INC
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site used in surgery to treat femoral neck fractures, most often suffered by the elderly, and other fractures from auto-related and other accidents; joint prostheses, which replaces natural joints and restores functions dama…
Full company profileJapan Medical Dynamic Marketing INC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Japan Medical Dynamic Marketing INC annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 13.6B | 14.8B | 16.7B | 18.1B | 16.7B | 19.2B | 21.3B | 23.2B | 25.1B | 23.9B | 21.3B |
| Gross Profit | 9.71B | 10.6B | 11.8B | 12.8B | 11.4B | 13.0B | 14.0B | 14.8B | 15.6B | 14.1B | 11.7B |
| Operating Income | 1.91B | 2.05B | 2.23B | 2.64B | 2.17B | 2.66B | 2.02B | 1.75B | 1.56B | 574M | -2.10B |
| EBITDA | - | 2.87B | 3.44B | 4.08B | 3.46B | 4.20B | 3.34B | 3.26B | 1.40B | 2.31B | -467M |
| Net Income | 1.13B | 1.43B | 1.98B | 2.16B | 1.66B | 2.14B | 1.42B | 1.27B | -462M | 263M | -1.67B |
| EPS | 43 | 54 | 75 | 82 | 63 | 81 | 54 | 48 | -18 | 9.98 | -63 |
| Balance Sheet | |||||||||||
| Total Assets | 21.5B | 20.9B | 23.5B | 24.9B | 25.2B | 27.3B | 29.4B | 31.5B | 33.7B | 35.7B | 35.4B |
| Total Liabilities | 9.25B | 7.61B | 8.26B | 7.92B | 6.48B | 5.85B | 6.14B | 5.88B | 8.93B | 10.3B | 10.6B |
| Shareholders' Equity | 12.3B | 13.2B | 15.2B | 16.9B | 18.6B | 21.4B | 23.2B | 25.5B | 24.7B | 25.4B | 24.8B |
| Cash & Short-term Investments | 2.79B | 2.46B | 2.26B | 2.51B | 2.47B | 2.59B | 2.80B | 2.32B | 3.18B | 3.11B | 2.56B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.04B | 2.56B | 2.37B | 2.73B | 2.60B | 3.11B | 2.19B | 2.10B | 1.05B | 206M | - |
| Capital Expenditure | 1.06B | 1.00B | 1.98B | 1.65B | 1.35B | 1.59B | 1.32B | 1.80B | 1.67B | 2.00B | 0.00 |
| Free Cash Flow | - | 1.55B | 274M | 946M | 1.23B | 1.53B | 871M | 302M | -620M | -1.79B | - |
| Ratios | |||||||||||
| ROE | 9.2% | 10.8% | 13.1% | 12.8% | 8.9% | 10.0% | 6.1% | 5.0% | -1.9% | 1.0% | -6.7% |
| ROA | 5.2% | 6.8% | 8.4% | 8.7% | 6.6% | 7.8% | 4.8% | 4.0% | -1.4% | 0.7% | -4.7% |
| Net Profit Margin | 8.3% | 9.6% | 11.9% | 12.0% | 9.9% | 11.1% | 6.7% | 5.5% | -1.8% | 1.1% | -7.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Japan Medical Dynamic Marketing INC dividends
- Dividend yield
- 5.53%
- Forward dividend
- 0.09 EUR
- Payout ratio
- 150.8%
- Ex-dividend date
- Mar 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 397M | 15 | 150.8% |
| 2025 | JPY 371M | 14 | - |
| 2024 | JPY 344M | 13 | 27.0% |
| 2023 | JPY 317M | 12 | 22.3% |
| 2022 | JPY 290M | 11 | 13.6% |
| 2021 | JPY 264M | 10 | 15.9% |
| 2020 | EUR 238M | 9.02 | 11.0% |
| 2019 | EUR 210M | 7.95 | 10.6% |
| 2018 | EUR 185M | 7.01 | 13.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Japan Medical Dynamic Marketing INC
- Insiders 45.56%
- Institutions 17.44%
- Public & others 37.00%
- Shares outstanding 26.4M
- Free float 14.9M
Japan Medical Dynamic Marketing INC company profile
- Company name
- Japan Medical Dynamic Marketing INC
- Ticker
- JMD.F
- ISIN
- JP3689100000
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 539
- Fiscal year end
- March
- Address
- 12-2, Ichigayadaimachi, Shinjuku, Japan, 162-0066
- Phone
- 81 3 3341 6545
- Website
- jmdm.co.jp
About Japan Medical Dynamic Marketing INC
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site used in surgery to treat femoral neck fractures, most often suffered by the elderly, and other fractures from auto-related and other accidents; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury, such as hip and knee joint products; spinal fixation devices to fix spinal instability directly through corrective surgery; and artificial bones that are used to fill gaps in bone defects caused by bone fractures or bone tumors. It offers its products to doctors, medical institutions, and hospitals. The company was incorporated in 1973 and is headquartered in Shinjuku, Japan.
Japan Medical Dynamic Marketing INC management
9- Mr. Toshiyuki HironakaPresident & Representative Director · born 1962
- Naoto SawakiExecutive Officer and GM of Administration & SCM
- Shinji MunechikaDirector of IR
- Koichi KondoExecutive Officer and Head of China Operations & Spine Business Development · born 1967
- Mr. Yasuaki HidakaSenior Executive Officer & Head of Trauma Business Development · born 1970
- Shinichi MiyataExecutive Officer and GM of Regulatory Affairs & Development Division
- Takeshi YamamotoExecutive Officer
- Tomoyuki YamamotoExecutive Officer, Deputy GM of the Business Division & GM of the Joint Business Department
- Takeru YamamotoExecutive Officer & Head of the Business Division